Alpha Teknova (NASDAQ:TKNO) Stock Price Down 11.7%

Alpha Teknova, Inc. (NASDAQ:TKNOGet Free Report)’s stock price fell 11.7% on Monday . The stock traded as low as $1.20 and last traded at $1.21. 96,900 shares changed hands during mid-day trading, an increase of 400% from the average session volume of 19,367 shares. The stock had previously closed at $1.37.

Wall Street Analyst Weigh In

Several research firms recently weighed in on TKNO. Stephens reaffirmed an “overweight” rating and issued a $15.00 price objective on shares of Alpha Teknova in a research note on Tuesday, May 14th. BTIG Research lowered Alpha Teknova from a “buy” rating to a “neutral” rating in a research note on Tuesday, March 12th.

Read Our Latest Research Report on TKNO

Alpha Teknova Stock Performance

The company has a fifty day moving average price of $1.72 and a two-hundred day moving average price of $2.58. The company has a debt-to-equity ratio of 0.16, a current ratio of 5.52 and a quick ratio of 3.92. The company has a market capitalization of $49.39 million, a P/E ratio of -1.15 and a beta of 0.34.

Alpha Teknova (NASDAQ:TKNOGet Free Report) last posted its earnings results on Monday, May 13th. The company reported ($0.20) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.04. The firm had revenue of $9.29 million for the quarter, compared to analyst estimates of $7.80 million. Alpha Teknova had a negative net margin of 97.85% and a negative return on equity of 38.24%. During the same period in the previous year, the firm posted ($0.31) EPS. Equities analysts forecast that Alpha Teknova, Inc. will post -0.65 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. State Board of Administration of Florida Retirement System acquired a new stake in shares of Alpha Teknova in the first quarter valued at about $35,000. FourWorld Capital Management LLC acquired a new stake in shares of Alpha Teknova in the first quarter valued at about $135,000. Fielder Capital Group LLC acquired a new stake in shares of Alpha Teknova in the fourth quarter valued at about $156,000. Redmile Group LLC increased its stake in shares of Alpha Teknova by 6.5% in the first quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock valued at $434,000 after buying an additional 10,448 shares during the period. Finally, Conestoga Capital Advisors LLC increased its stake in shares of Alpha Teknova by 4.1% in the fourth quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after buying an additional 9,800 shares during the period. 13.81% of the stock is owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

See Also

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.